家族性癌症史患者一级亲属的需求研究进展

doi:10.11904/j.issn.1002-3070.2022.01.018

Abstract

Abstract: The first-degree relatives of patients with familial cancer often have anxiety,tension,fear and other emotions due to genetic susceptibility,which affect their normal social interaction and work.To identify the needs of relatives as early as possible,this article reviews the current needs,influencing factors,and evaluation tools of the first-degree relatives of familial cancer patients with a view to providing systematic and effective supportive intervention.

Key words: Familial cancer, First-degree relatives, Needs

CLC Number:

HUANG Meimei, LUO Ruijun, WENG Yiming, RUAN Peng. Research progress on the needs of first-degree relatives of patients with family cancer history[J]. Journal of Practical Oncology, 2022, 36(1): 94-98.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.01.018

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I1/94

References

1 GBD 2015 Mortality and Causes of Death Collaborators.Global,regional,and national life expectancy,all-cause mortality,and cause-specific mortality for 249 causes of death,1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet,2016,388(10053):1459-1544.
2 Eijzenga W,de Geus E,Aalfs CM,et al.How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial[J].Patient Educ Couns,2018,101(9):1611-1619.
3 San Miguel-Majors SL,Whitaker DE,Davis BC,et al.Education on cancer risk assessment and genetic counseling to address cancer health disparities among racial/ethnic groups and rural populations:Implementing culturally tailored outreach through community health educators[J].J Genet Couns,2020,29(2):243-246.
4 Wood ME,Rehman HT,Bedrosian I.Importance of family history and indications for genetic testing[J].Breast J,2020,26(1):100-104.
5 Kastrinos F,Samadder NJ,Burt RW.Use of family history and genetic testing to determine risk of colorectal cancer[J].Gastroenterology,2020,158(2):389-403.
6 Lee SD,Kim BC,Han KS,et al.Influence of family history on survival in patients with colon and rectal cancer[J].J Dig Dis,2014,15(3):108-115.
7 刘娜,王临池,胡一河,等.一级亲属癌症史对胃肠道癌症的遗传倾向影响[J].上海预防医学,2018,30(12):1020-1024.
8 Mcdonald F,Patterson P,White KJ,et al.Correlates of unmet needs and psychological distress in adolescent and young adults who have a parent diagnosed with cancer[J].Psycho Oncology,2015,25(4):447-454.
9 Ellis SJ,Wakefield CE,Antill G,et al.Supporting children facing a parent's cancer diagnosis:a systematic review of children's psychosocial needs and existing interventions[J].Eur J Cancer Care(Engl),2017,26(1):10.
10 Mcdonald F,Patterson P,White KJ,et al.Predictors of unmet needs and psychological distress in adolescent and young adult siblings of people diagnosed with cancer[J].Psycho Oncology,2015,24(3):333-340.
11 Alderfer MA,Long KA,Lown EA,et al.Psychosocial adjustment of siblings of children with cancer:a systematic review[J].Psychooncology,2010,19(8):789-805.
12 王雯雯,刘文斌,曹广文.胃癌发病性别差异的相关危险因素[J].上海预防医学,2017,29(4):257-260.
13 Ren ZJ,Cao DH,Zhang Q,et al.First-degree family history of breast cancer is associated with prostate cancer risk:a systematic review and meta-analysis[J].BMC Cancer,2019,19(1):871.
14 Bourdeaut F,Miquel C,Richer W,et al.Rubinstein-Taybi syndrome predisposing to non-WNT,non-SHH,group 3 medulloblastoma[J].Pediatr Blood Cancer,2014,61(2):383-386.
15 Hoskins LM,Werner-Lin A,Greene MH.In their own words:treating very young BRCA1/2 mutation-positive women with care and caution[J].PLoS One,2014,9(2):e87696.
16 Mcdonald F,Patterson P,Tindle R.What young people need when a family member dies of cancer[J].Support Care Cancer,2020,28(4):1631-1638.
17 Brunstrom K,Murray A,Mcallister M.Experiences of women who underwent predictive BRCA 1/2 mutation testing before the age of 30[J].J Genet Couns,2016,25(1):1-11.
18 Patterson P,Pearce A,Slawitschka E.The initial development of an instrument to assess the psychosocial needs and unmet needs of young people who have a parent with cancer:piloting the offspring cancer needs instrument(OCNI)[J].Support Care Cancer,2011,19(8):1165-1174.
19 Patterson P,Mcdonald F,Butow P,et al.Psychometric evaluation of the sibling cancer needs instrument(SCNI):an instrument to assess the psychosocial unmet needs of young people who are siblings of cancer patients[J].Support Care Cancer,2014,22(3):653-665.
20 Patterson P,Mcdonald F,Costa D,et al.Initial validation of a needs instrument for young people bereaved by familial cancer[J].Support Care Cancer,2020,28(8):3637-3648.
21 Lakhani NS,Weir J,Allford A,et al.Could triaging family history of cancer during palliative care enable earlier genetic counseling intervention[J].J Palliat Med,2013,16(11):1350-1355.
22 李佩琼,章远志,申本昌,等.遗传咨询为生物技术专业打开就业新局面——遗传咨询的初步教学实践[J].现代职业教育,2020,(40):78-80.
23 Ginoza M,Isasi R.Regulating preimplantation genetic testing across the World:a comparison of international policy and ethical perspectives[J].Cold Spring Harb Perspect Med,2019,10(5):36681.
24 Bowen DJ,Hay JL,Harris-Wai JN,et al.All in the family communication of cancer survivors with their families[J].Fam Cancer,2017,16(4):597-603.
25 Rodríguez VM,Corona R,Bodurtha JN,et al.Family ties:the role of family context in family health history communication about cancer[J].J Health Commun,2016,21(3):346-355.
26 陶红竹,张欢,夏蜀凤,等.家族性乳腺癌患者一级亲属早期筛查干预效果评估[J].中华普外科手术学杂志(电子版),2017,11(6):488-490.
27 Drake I,Dias JA,Teleka S,et al.Lifestyle and cancer incidence and mortality risk depending on family history of cancer in two prospective cohorts[J].Int J Cancer,2020,146(5):1198-1207.
28 Allen K.The importance of food,nutrition and physical activity in cancer prevention:an interview with Dr Kate Allen[J].Future Oncol,2018,14(15):1427-1429.
29 Hidaka A,Sawada N,Svensson T,et al.Family history of cancer and subsequent risk of cancer:a large-scale population-based prospective study in Japan[J].Int J Cancer,2020,147(2):331-337.

[1]	WANG Yanping, QIU Lin, WU Meng, SA Rina. Analysis of the incidence and mortality of malignant tumors in Shaanxi province in 2016 [J]. Journal of Practical Oncology, 2022, 36(1): 1-6.
[2]	ZHANG Yiyi, LI Qi, LIU Xu, WANG Yanan, ZOU Yuanjie, ZHOU Huihui, XU Chunyan, SU Shengqi, GE Xin, WANG Tong. Analysis of 5-year survival and its influencing factors of patients with cervical cancer [J]. Journal of Practical Oncology, 2022, 36(1): 7-13.
[3]	WANG Zongwen, LI Xiaodong, ZHU Qiankun, ZENG Shicong, ZHAI Bo. KIF14 in the mechanism of acquired drug resistance in hepatocellular carcinoma SMCC-7721 cells [J]. Journal of Practical Oncology, 2022, 36(1): 14-19.
[4]	ZHANG Mengru, CAO Dedong, GE Wei. Comparison of efficacy and safety of Endostar intravenous continuous pumping and dripping combined with platinum-containing dual-drug regimen chemotherapy for the treatment of advanced non-small cell lung cancer [J]. Journal of Practical Oncology, 2022, 36(1): 20-25.
[5]	BU Jianlong, ZHANG Pinyi, NI Boxiong, YU Xiran, NING Jinfeng. Analysis of risk factors for lymph node metastasis in early lung adenocarcinoma [J]. Journal of Practical Oncology, 2022, 36(1): 26-30.
[6]	ZHAO Baoshan, LIANG Guanying, XU Shengjie, QIAO Hui, CHEN Hongxia, MA Ying, JU Xueping, WANG Lin. Analysis of the correlation between PELP1 expression and gastric cancer progression and prognosis [J]. Journal of Practical Oncology, 2022, 36(1): 31-36.
[7]	LI Weihua, ZHANG Guangfeng, MA Lili, HE Pin, WANG Wen, LI Dingfu. Construction of a breast cancer prognostic model based on metabolism-related genes in the TCGA database [J]. Journal of Practical Oncology, 2022, 36(1): 37-43.
[8]	WANG Yuping, SI Meili, SUN Xiaoxia, GUO Yulin. High expression of HPIP in endometrial carcinoma and its significance in the analysis of survival and prognosis [J]. Journal of Practical Oncology, 2022, 36(1): 44-48.
[9]	LIU Jinshuang, ZHAGN Wenjing, LI Qingwei, LI Zhiwei. Research progress of therapies combined immune checkpoint inhibitors in pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(1): 49-53.
[10]	DONG Lina, LIANG Tian, ZHANG Xian, ZHANG Guangmei. Research progress on tropism of ovarian cancer to fat-rich omentum organs [J]. Journal of Practical Oncology, 2022, 36(1): 54-58.
[11]	SHI Jingtong, CHEN Minjie, SUN Yihua. Research progress in the role of malignant tumor-derived exosomes in the M2 polarization of macrophages [J]. Journal of Practical Oncology, 2022, 36(1): 59-63.
[12]	ZHANG Wenjing, LIU Jinshuang, WANG Dan, LI Qingwei, LI Zhiwei. Research status of neoadjuvant therapy for pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(1): 64-68.
[13]	MENG Xin, LU Jinyue, ZHANG Ailin, HE Luwen. Research progress on antitumor medicinal substances and pharmacological activities of Radix Actinidia chinensis [J]. Journal of Practical Oncology, 2022, 36(1): 69-73.
[14]	WANG Yang, LI Guodong, TANG Qingchao, LIU Ming. Research progress of acidosis in colorectal malignant tumors [J]. Journal of Practical Oncology, 2022, 36(1): 74-78.
[15]	WANG Siran, HU Weiping. Research progress of immune checkpoint inhibitors in the treatment of oral squamous cell carcinoma [J]. Journal of Practical Oncology, 2022, 36(1): 79-83.

Research progress on the needs of first-degree relatives of patients with family cancer history

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments